Medicare GLP-1 Bridge: $50 Cost, Eligibility and Access

If you have Medicare, “weight-loss drugs are not covered” is no longer a complete answer. A temporary federal program now gives some beneficiaries a separate access route.

The important distinction is the route: the Medicare GLP-1 Bridge does not remove the ordinary Part D weight-loss exclusion or approve every person who wants a GLP-1.

What is the Medicare GLP-1 Bridge?

CMS describes it as a short-term demonstration running from July 1, 2026 to December 31, 2027. It operates outside Part D's normal coverage and payment flow, using a central processor rather than requiring each plan sponsor to opt in¹.

That matters if an older article or plan discussion stopped at the standard weight-loss exclusion. Ask whether you qualify for the Bridge, while keeping your regular Part D coverage questions separate.

Who might qualify?

Medicare's beneficiary guidance requires age 18 or older, qualifying Medicare drug coverage and one of these clinical pathways when GLP-1 therapy starts²:

These are screening criteria, not a prescription recommendation. Your clinician and the program determine eligibility from the medical record.

Medicare says people already receiving GLP-1 coverage through Part D, or with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, should use the ordinary plan coverage route rather than the Bridge². Do not stop a covered medicine or try to change a diagnosis to fit the demonstration.

Which medicines are included?

Medicare's current page lists Foundayo tablets, Wegovy injections or tablets, and Zepbound KwikPen. It excludes single-dose Zepbound pens and vials from this program².

That product distinction matters. Tell your clinician and pharmacist you are asking about Bridge access so that the prescription and authorization identify an included product. A different device or a compounded vial should not be assumed eligible.

For comparisons, read Wegovy vs Zepbound or Foundayo vs the Wegovy pill. Eligibility and suitability are still medical decisions.

What does the $50 payment include?

CMS specifies a $50 copay for eligible medication furnished under the demonstration. The Part D deductible does not apply, the payment does not count toward Part D true out-of-pocket costs, and the Bridge does not provide the low-income subsidy for that copay¹.

Ask separately about any appointment charges. A medication copay does not promise that every clinic service, coaching package or visit is free.

How do you get started?

1. 1.Check the Medicare beneficiary eligibility page and your Medicare drug coverage.
2. 2.Ask your clinician whether a covered medicine is appropriate for you.
3. 3.Ask the office to prescribe through the Bridge, certify that treatment is part of a diet-and-exercise lifestyle program, and complete prior authorization when requested².
4. 4.Confirm the pharmacy can process the approved Bridge prescription before assuming the $50 price applies.
5. 5.Keep the approval notice and ask how refills or medication changes will be handled.

CMS's provider newsletter describes the Bridge prescription and authorization process³. Medicare's current beneficiary guidance says the provider must complete prior authorization when requested and certify use within a lifestyle program focused on diet and exercise². This is not a manufacturer savings card and should not be confused with a commercial-insurance coupon.

What if you do not qualify?

Ask your Part D plan about coverage for an applicable non-weight-loss indication. If neither route applies, compare appropriate treatment and payment options with your clinician. Our insurance guide and semaglutide cost guide can help organize those conversations.

Do not cancel drug coverage because a temporary program sounds cheaper. Check the program dates and the complete cost of your care first. These details were checked against CMS and Medicare guidance on October 14, 2026; use their current pages before a new application.